Dose Escalation Study with Bispecific Antibodies in Adult Patients with Lupus Nephritis
R5459-1979-LN-2459
Phase 1 other active
Quick answer
Dose Escalation Study with Bispecific Antibodies in Adult Patients with Lupus Nephritis for Lupus Nephritis is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Lupus Nephritis
- Phase
- Phase 1
- Modality
- other
- Status
- active